We used T18 antibody that recognizes misfolded tau aggregates (31) with a commercially available Total tau antibody for immunofluorescence and Tau 13 antibody for coimmunoprecipitation (co-IP) assays of AD brain tissues. This evidence concerns the gene MAPT and Alzheimer disease.